USPTO serial 79200664
STEMMACS
Reviewed by CopyMark Law Group
Reg. 5268524Status 739Renewal
- Filing date
- Status date
- Registration date
- Aug 22, 2017
- Examiner
- LAM, HAI-LY HUYNH
- Law office
- GENERIC WEB UPDATE
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with STEMMACS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $748*
Plus Government fees of $1,300
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
51429 Bergisch Gladbach, DE
51429 Bergisch Gladbach, DE
51429 Bergisch Gladbach, DE
Bergisch Gladbach, DE
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Peter S. Sloane
Peter S. Sloane Leason Ellis LLPOne North Lexington Ave., Suite 1200White Plains, NY 10601United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical, biological and biochemical preparations for industrial, scientific and non-medical diagnostic purposes, namely, chemical preparations for use in industry and biological preparation for use in cell cultures other than for medical or veterinary use; reagents, media, substances and constituent parts for preparing media, namely, biochemical, chemical or diagnostic reagents for nonmedical purposes, cell culture media for growing cells for use in scientific research, cytokines and cell culture growth factors, small molecules, proteins and serum fractions, all being used in industry and science and for use in medical laboratories; buffer solutions and reagents for use with laboratory apparatus, in particular separation apparatus, analysis apparatus, reactors and imaging apparatus for research purposes; reagents for scientific and research use, namely, for processing biological material, in particular tissues, bone marrow, cells, blood and components thereof, and for processing primary and established cell lines and cell cultures, other than for medical or veterinary purposes; diagnostic reagents and preparations for scientific purposes and for use in medical laboratories; microorganism culture media, cell culture media, sperm freezing media, cryogenic preparations in solid, liquid or gas state for use in freezing, contrast media, contrast media for in-vivo imaging, all being for scientific purposes; reagents, other than for medical or veterinary purposes, namely, for use in biotechnology, in biological treatment processes and in the biotechnological industry; nucleic acids, oligonucleotides and nucleotides for scientific research and laboratory use, namely, for insertion into cells; molecules, other than for medical or veterinary purposes, namely, for manipulating biological material, in particular for manipulating tissues, bone marrow, cells, blood and cell cultures | ACTIVE | — |
| 005 | Reagents, media, substances and components for the preparation of media, namely, reagents and media for medical or veterinary diagnostic purposes, contrast media for in-vivo imaging; buffer solutions and reagents for use with medical apparatus, in particular separation apparatus, analyzing apparatus, reactors and imaging apparatus for medical and veterinary diagnostic purposes; reagents for medical use, namely, for processing biological material, in particular tissues, bone marrow, cells, blood and components thereof; microorganism culture media, cell culture media for cultivating microorganisms, freezing media for use in in-vitro fertilization consisting primarily of sperm freezing media and to store blood components, all for medical and veterinary use; pharmaceutical preparations for cellular therapy; nucleic acids, oligonucleotides and nucleotides for insertion into cells for medical purposes; molecules for medical or veterinary purposes, namely, for manipulating biological material, in particular for manipulating tissues, bone marrow, cells, blood and cell cultures; all the aforementioned goods not being medicinal products for direct treatment of cardiac diseases | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Miltenyi Biotec GmbH
- Other trademarks owned by Miltenyi Biotec GmbH
- Other trademarks owned by Miltenyi Biotec GmbH
- Other trademarks owned by Miltenyi Biotec B.V. & Co. KG
- Other trademarks in Class 001
- Other trademarks in Class 005
- Similar marks named STEMMACS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 1, 2026 | RNWL | INTERNATIONAL REGISTRATION RENEWED | — |
| Aug 22, 2026 | REM4 | COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED | — |
| Jul 15, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jul 15, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 15, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Oct 7, 2023 | NA75 | NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED | — |
| Oct 7, 2023 | C75A | REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK. | — |
| Oct 7, 2023 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Mar 17, 2023 | ES75 | TEAS SECTION 71 & 15 RECEIVED | — |
| Aug 22, 2022 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Feb 20, 2020 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Dec 5, 2019 | CHLD | CHANGE OF OWNER RECEIVED FROM IB | — |
| Dec 22, 2017 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Dec 6, 2017 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Dec 6, 2017 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Nov 22, 2017 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Aug 22, 2017 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 6, 2017 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 6, 2017 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 17, 2017 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 4, 2017 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Apr 28, 2017 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 26, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 26, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 26, 2017 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Apr 18, 2017 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Apr 18, 2017 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Apr 18, 2017 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Apr 6, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 6, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 5, 2017 | ALIE | ASSIGNED TO LIE | — |
| Mar 21, 2017 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 24, 2017 | RFNT | REFUSAL PROCESSED BY IB | — |
| Feb 7, 2017 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Feb 7, 2017 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Feb 4, 2017 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Feb 3, 2017 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 31, 2017 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jan 27, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 27, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 26, 2017 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |